21 Jun 2017
Research brief: Developing a “roadmap” for the second deadliest cancer worldwide
Scientists have a new tool to tackle the second leading cause of cancer death, thanks to work from The Cancer Genome Atlas...Read More
10 May 2017
Research brief: New understanding of lethal women’s cancer
TCGA publishes molecular profile of uterine carcinosarcoma, offers potential new treatment options Researchers from The Cancer Genome Atlas, including Van Andel Research...Read More
14 Mar 2017
Four molecular subtypes revealed in rare bile duct cancer
The short version Scientists now have a new resource for studying a rare bile duct cancer that may serve as a blueprint...Read More
17 Nov 2016
Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis
GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from...Read More
5 Nov 2015
TCGA findings provide molecular background for second most common kidney cancer
GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have molecularly characterized two...Read More